Back
Regenxbio Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
50
RGNX
Regenxbio
Last Price:
11.17
Seasonality Move:
-2.54%
Buy
68
VRTX
Vertex Pharmaceuticals
Last Price:
516.82
Seasonality Move:
6.39%
Sell
50
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $11.16. The Score for RGNX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $516.74. The Score for VRTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGNX Stock Price Chart
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $516.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 62.82 | Buy |
| Chaikin Money Flow: | -161568 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.94 - 10.44) | Buy |
| Bollinger Bands (100): | (10.06 - 12.9) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.32 | Buy |
| Relative Strength Index (14 RSI): | 69.1 | Buy |
| Chaikin Money Flow: | 707634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (463.95 - 492.55) | Buy |
| Bollinger Bands (100): | (466.25 - 490.85) | Buy |
RGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.46 | Buy |
| 20-day SMA: | 9.75 | Buy |
| 50-day SMA: | 10.61 | Buy |
| 200-day SMA: | 14.38 | Sell |
| 8-day EMA: | 9.93 | Buy |
| 20-day EMA: | 9.81 | Buy |
| 50-day EMA: | 10.49 | Buy |
| 200-day EMA: | 13.5 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 488.53 | Buy |
| 20-day SMA: | 482.44 | Buy |
| 50-day SMA: | 475.32 | Buy |
| 200-day SMA: | 451.94 | Buy |
| 8-day EMA: | 493.73 | Buy |
| 20-day EMA: | 483.69 | Buy |
| 50-day EMA: | 477.92 | Buy |
| 200-day EMA: | 450.84 | Buy |
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $3.91 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.57 per share, and an increase next year of $18.26 per share.
Regenxbio Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||